The effect of the AMPA/kainate receptor antagonist LY293558 in a rat model of postoperative pain

被引:47
|
作者
Lee, Hae-Jin
Pogatzki-Zahn, Esther M.
Brennan, Timothy J.
机构
[1] Univ Iowa, Dept Anesthesia, Coll Med, Iowa City, IA 52242 USA
[2] Univ Munster, Klin & Poliklin Anesthesiol & Operat Intens Med, D-4400 Munster, Germany
来源
JOURNAL OF PAIN | 2006年 / 7卷 / 10期
关键词
glutamate; incision; nonNMDA; hyperalgesia;
D O I
10.1016/j.jpain.2006.03.010
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Non-N-methyl-D-aspartate (non-NMDA) glutamate receptor antagonists modify multiple pain transmission pathways and are of particular interest in analgesic development because of their capacity to interfere with evoked pain. Evoked pain is a problem for postoperative patients and is characteristic of the plantar incision model for postoperative pain. The purpose of this study was to assess the efficacy of a non-NMDA receptor antagonist LY293558 on mechanical hyperalgesia after plantar incision in the rat. Parenteral, intrathecal, or intraplantar administration of LY293558 was tested against the mechanical hyperalgesia that characterizes the model. Sprague-Dawley rats were assigned to 1 of 3 groups. LY293558 or vehicle was administered intraperitoneally, intrathecally, or intraplantarly. The hind paw withdrawal threshold to punctate stimulation by using von Frey filaments and response frequency to a nonpunctate stimulus directly to the wound were measured. Motor tests after administration of LY293558 were also examined in rats that did not undergo incision. The greatest dose of parenterally administered LY293558 (34 mu mol/kg) decreased the responses to mechanical stimuli after plantar incision. Rotorod performance was decreased at these same times. Intrathecal injection of LY293558 (0.5 and 2.0 nmol) produced inhibition of mechanical sensitivity and produced lower extremity motor side effects. Repeated intrathecal administration produced sustained anesthesia for 24 hours but had no analgesic effect the next day. Local administration did not decrease response after incision. LY293558 was most effective for evoked pain when administered intrathecally. Perspective: Control of evoked pain after surgery is inadequate but is linked to perioperative outcome. These data suggest that non-NMDA receptor antagonists like LY293558 will be most effective for evoked pain in postoperative patients if administered spinally. (c) 2006 by the American Pain Society
引用
收藏
页码:768 / 777
页数:10
相关论文
共 50 条
  • [21] AMPA receptor antagonist LY293558 reverses preproenkephalin mRNA overexpression in the striatum of 6-OHDA-lesioned-rats treated with L-dopa
    Périer, C
    Marin, C
    Bonastre, M
    Tolosa, E
    Hirsch, EC
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2002, 16 (11) : 2236 - 2240
  • [22] Effect of intrathecal non-NMDA EAA receptor antagonist LY293558 in rats - A new class of drugs for spinal anesthesia
    Von Bergen, NH
    Subieta, A
    Brennan, TJ
    ANESTHESIOLOGY, 2002, 97 (01) : 177 - 182
  • [23] The AMPA/kainate receptor antagonist, LY 300164, increases the anticonvulsant effects of diazepam
    Borowicz, KK
    Kleinrok, Z
    Czuczwar, SJ
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2000, 361 (06) : 629 - 635
  • [24] The AMPA/kainate receptor antagonist, LY 300164, increases the anticonvulsant effects of diazepam
    Kinga K. Borowicz
    Zdzisław Kleinrok
    Stanisław J. Czuczwar
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2000, 361 : 629 - 635
  • [25] Comparing the Antiseizure and Neuroprotective Efficacy of LY293558, Diazepam, Caramiphen, and LY293558-Caramiphen Combination against Soman in a Rat Model Relevant to the Pediatric Population
    Apland, James P.
    Aroniadou-Anderjaska, Vassiliki
    Figueiredo, Taiza H.
    Pidoplichko, Volodymyr I.
    Rossetti, Katia
    Braga, Maria F. M.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2018, 365 (02): : 314 - 326
  • [26] Acute subthalamic administration of LY293558, an AMPA glutamate antagonist, attenuates striatal TH depletion in rats with a partial lesion of the nigrostriatal pathway
    Bonastre, M
    Marin, C
    Jiménez, A
    Tolosa, E
    MOVEMENT DISORDERS, 2002, 17 : S93 - S93
  • [27] Efficacy of the GluK1/AMPA Receptor Antagonist LY293558 against Seizures and Neuropathology in a Soman-Exposure Model without Pretreatment and its Pharmacokinetics after Intramuscular Administration
    Apland, James P.
    Aroniadou-Anderjaska, Vassiliki
    Figueiredo, Taiza H.
    Green, Carol E.
    Swezey, Robert
    Yang, Chun
    Qashu, Felicia
    Braga, Maria F. M.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2013, 344 (01): : 133 - 140
  • [28] Intrathecal MK801, an NMDA antagonist, potentiates CNQX, an AMPA-kainate receptor antagonist, in a postoperative incisional pain model in rats
    Nath, HA
    Rakic, AM
    Victor, A
    Ivankovich, AD
    ANESTHESIOLOGY, 2000, 93 (3A) : U202 - U202
  • [29] A selective AMPA antagonist, LY293558, suppresses morphine withdrawal-induced activation of locus coeruleus neurons and behavioral signs of morphine withdrawal
    Rasmussen, K
    Kendrick, WT
    Kogan, JH
    Aghajanian, GK
    NEUROPSYCHOPHARMACOLOGY, 1996, 15 (05) : 497 - 505
  • [30] The effect of NMDA receptor antagonist and AMPA/kainate receptor antagonist on licking frequency rats
    Vajnerova, O
    Brozek, G
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2000, 12 : 153 - 153